TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/9/21 16:15 | 9/8/21 | CGEM | Cullinan Oncology, Inc. | Health | BioPrd | Biological Products, (No Diag | Baeuerle Patrick | MA | O | See Rema | M.d | 47 | 4.30 | 0 | 11 | 3 | 341 | D | |||||||||||||||
9/9/21 16:15 | 9/8/21 | CGEM | Cullinan Oncology, Inc. | Health | BioPrd | Biological Products, (No Diag | Baeuerle Patrick | MA | O | See Rema | S.d | -313 | 28.45 | 0 | -11 | -3 | 341 | D | |||||||||||||||
8/26/21 19:11 | 8/10/21 | CGEM | Cullinan Oncology, Inc. | Health | BioPrd | Biological Products, (No Diag | Baeuerle Patrick | MA | O | See Rema | M.d | 47 | 4.30 | 0 | 11 | 3 | 341 | D | |||||||||||||||
8/26/21 19:11 | 8/10/21 | CGEM | Cullinan Oncology, Inc. | Health | BioPrd | Biological Products, (No Diag | Baeuerle Patrick | MA | O | See Rema | S.d | -297 | 27.00 | 0 | -11 | -3 | 341 | D | |||||||||||||||
12/30/19 17:32 | 12/27/19 | HARP | Harpoon Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Baeuerle Patrick | CA | D | S | -1,396 | 15.98 | 0 | -87 | -25 | 262 | I | |||||||||||||||
12/26/19 17:30 | 12/20/19 | TCRR | Tcr2 Therapeutics Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Baeuerle Patrick | MA | D | S.m | -1,796 | 15.36 | 0 | -117 | -25 | 351 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |